These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 23867451)

  • 1. J wave is associated with increased risk of sudden cardiac arrest in patients with hypertrophic cardiomyopathy.
    Li Y; Mao J; Yan Q; Qi S; Liu X; Tan C; Zhang Y; Shi L; Tian Y; Wu Y; Zeng Y; Wang J; Chu J; Ma C; Liu X; Yang X
    J Int Med Res; 2013 Aug; 41(4):1281-90. PubMed ID: 23867451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ST-segment depression as a risk factor in hypertrophic cardiomyopathy.
    Haghjoo M; Mohammadzadeh S; Taherpour M; Faghfurian B; Fazelifar AF; Alizadeh A; Rad MA; Sadr-Ameli MA
    Europace; 2009 May; 11(5):643-9. PubMed ID: 19164362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. J Waves for Predicting Cardiac Events in Hypertrophic Cardiomyopathy.
    Tsuda T; Hayashi K; Konno T; Sakata K; Fujita T; Hodatsu A; Nagata Y; Teramoto R; Nomura A; Tanaka Y; Furusho H; Takamura M; Kawashiri MA; Fujino N; Yamagishi M
    JACC Clin Electrophysiol; 2017 Oct; 3(10):1136-1142. PubMed ID: 29759496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of sudden cardiac death with implantable cardioverter-defibrillators in children and adolescents with hypertrophic cardiomyopathy.
    Maron BJ; Spirito P; Ackerman MJ; Casey SA; Semsarian C; Estes NA; Shannon KM; Ashley EA; Day SM; Pacileo G; Formisano F; Devoto E; Anastasakis A; Bos JM; Woo A; Autore C; Pass RH; Boriani G; Garberich RF; Almquist AK; Russell MW; Boni L; Berger S; Maron MS; Link MS
    J Am Coll Cardiol; 2013 Apr; 61(14):1527-35. PubMed ID: 23500286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic difference between paroxysmal and non-paroxysmal atrial fibrillation in patients with hypertrophic cardiomyopathy.
    Yashiro B; Minami Y; Terajima Y; Hagiwara N
    J Cardiol; 2014 Jun; 63(6):432-7. PubMed ID: 24280311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The relationship between QT dispersion and risk factors of sudden death in hypertrophic cardiomyopathy].
    Göktekin O; Ritsushi K; Matsumoto K; Hiroshi M
    Anadolu Kardiyol Derg; 2002 Sep; 2(3):226-30. PubMed ID: 12223331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myocardial bridging, a frequent component of the hypertrophic cardiomyopathy phenotype, lacks systematic association with sudden cardiac death.
    Basso C; Thiene G; Mackey-Bojack S; Frigo AC; Corrado D; Maron BJ
    Eur Heart J; 2009 Jul; 30(13):1627-34. PubMed ID: 19406869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exercise-induced ventricular arrhythmias and risk of sudden cardiac death in patients with hypertrophic cardiomyopathy.
    Gimeno JR; Tomé-Esteban M; Lofiego C; Hurtado J; Pantazis A; Mist B; Lambiase P; McKenna WJ; Elliott PM
    Eur Heart J; 2009 Nov; 30(21):2599-605. PubMed ID: 19689975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk stratification and outcome of patients with hypertrophic cardiomyopathy >=60 years of age.
    Maron BJ; Rowin EJ; Casey SA; Haas TS; Chan RH; Udelson JE; Garberich RF; Lesser JR; Appelbaum E; Manning WJ; Maron MS
    Circulation; 2013 Feb; 127(5):585-93. PubMed ID: 23275385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Characteristics of cardiac arrhythmia in patients with hypertrophic cardiomyopathy].
    Wang Y; Cui YH; Wang DW
    Zhonghua Yi Xue Za Zhi; 2004 Mar; 84(5):401-4. PubMed ID: 15061995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computerized Q wave dimensions in athletes and hypertrophic cardiomyopathy patients.
    Bent RE; Wheeler MT; Hadley D; Froelicher V; Ashley E; Perez MV
    J Electrocardiol; 2015; 48(3):362-7. PubMed ID: 25732098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics and clinical significance of late gadolinium enhancement by contrast-enhanced magnetic resonance imaging in patients with hypertrophic cardiomyopathy.
    Rubinshtein R; Glockner JF; Ommen SR; Araoz PA; Ackerman MJ; Sorajja P; Bos JM; Tajik AJ; Valeti US; Nishimura RA; Gersh BJ
    Circ Heart Fail; 2010 Jan; 3(1):51-8. PubMed ID: 19850699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variables associated with contrast-enhanced cardiovascular magnetic resonance in hypertrophic cardiomyopathy: clinical implications.
    Payá E; Marín F; González J; Gimeno JR; Feliu E; Romero A; Ruiz-Espejo F; Roldán V; Climent V; de la Morena G; Valdés M
    J Card Fail; 2008 Jun; 14(5):414-9. PubMed ID: 18514934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Sudden death in hypertrophic obstructive and non-obstructive cardiomyopathy: can it be prevented?].
    Grobéty M; Schlaepfer J; Kappenberger L; Fromer M
    Schweiz Med Wochenschr; 1997 Apr; 127(15):623-30. PubMed ID: 9198888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation of the risk of sudden death in hypertrophic cardiomyopathy].
    Sadoul N; de Chillou C; Aliot E; McKenna WJ
    Arch Mal Coeur Vaiss; 1999 Apr; 92 Spec No 1():65-73. PubMed ID: 10326160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spectrum and prognostic significance of arrhythmias on ambulatory Holter electrocardiogram in hypertrophic cardiomyopathy.
    Adabag AS; Casey SA; Kuskowski MA; Zenovich AG; Maron BJ
    J Am Coll Cardiol; 2005 Mar; 45(5):697-704. PubMed ID: 15734613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy.
    Maron BJ; Shen WK; Link MS; Epstein AE; Almquist AK; Daubert JP; Bardy GH; Favale S; Rea RF; Boriani G; Estes NA; Spirito P
    N Engl J Med; 2000 Feb; 342(6):365-73. PubMed ID: 10666426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fragmented QRS as a candidate marker for high-risk assessment in hypertrophic cardiomyopathy.
    Kang KW; Janardhan AH; Jung KT; Lee HS; Lee MH; Hwang HJ
    Heart Rhythm; 2014 Aug; 11(8):1433-40. PubMed ID: 24813377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of intra-left ventricular electromechanical asynchrony in patients with hypertrophic cardiomyopathy.
    D'Andrea A; Caso P; Severino S; Cuomo S; Capozzi G; Calabrò P; Cice G; Ascione L; Scherillo M; Calabrò R
    Eur Heart J; 2006 Jun; 27(11):1311-8. PubMed ID: 16364972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sudden cardiac arrest in a young patient with hypertrophic cardiomyopathy and zero canonical risk factors: the inherent limitations of risk stratification in hypertrophic cardiomyopathy.
    Kohorst JJ; Bos JM; Hagler DJ; Ackerman MJ
    Congenit Heart Dis; 2014; 9(2):E51-7. PubMed ID: 23648018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.